FDA Investigator Jennifer L Schmidt
Jennifer L Schmidt has inspections in 2 countries as of 05 May 2023. Jennifer L Schmidt has collaborated with a combined 1921 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
05 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Switzerland
Co-Investigator(s):
A Williams,
Ademola O Daramola,
Alice S Tsao,
Anita R Michael,
Ann Marie Montemurro,
Anthony F Lorenzo,
Ashley L Reiber,
Ava M Bowman,
Benjamin J Smith,
Brentley S Collins,
Brian D Nicholson,
Burnell M Henry,
Carrie Ann Plucinski,
CDR Donald Ertel,
Charles M Spyr,
Cheng H Yen,
Christian D Lynch (CDL),
Claire M Minden,
Constantin Y Philopoulos,
Craig D Zagata,
Cynthia Jim, CSO,
David A Paterson,
David Perkins,
Deborah M Trout,
Debra I Love,
Destry M Sillivan,
Dino Feigelstock (DF), PhD,
Don H Bark, PhD,
Dr. Andrew Shroke,
Dr. Gang Wang, PhD,
Dr. Willie F Vann, PhD,
Edmund F Mrak, Jr,
Edmund Fmrakjr S,
Eliezar Ramos,
Emest F Bizjak,
Emily J Orban,
Enrico Joset Mangahis,
Esra Toussaint,
Gene D Arcy,
Gregory Price,
Helen B Ricalde,
Humera Khan,
Humera T Khan,
Ifueko Osemwota,
Jacqueline Mdiaz Albertini,
James E Keller, PhD,
James M Mason,
James R Evans,
Jason F Chancey,
Jeanne M Morris,
Jeffrey A Sommers,
Jeffrey D Meng,
Joan A Loreng,
John M Seale,
Jose Acruz Gonzalez,
Joseph George,
Joshua P Wireman,
Julie D Bringger,
Justin A Boyd,
Larry K Austin,
Laura Fontan, MS,
Laurie P Norwood,
LCDR Debra Emerson,
LCDR Randall L Morris,
Lori P Peters,
Marion Michaelis,
Marlene G Swider,
Martha T Olone,
Meisha R Sampson,
Meisha Waters,
Michele L Forster, PhD,
Michele L Glendenning,
Mihaly S Ligmond,
Nicole K Trudel,
Nikisha M Bolden,
Omotunde O Osunsanmi,
Patsy J Domingo,
Paula A Trost,
Peng Zhou,
Prabhu P Raju,
Ralph A Erickson,
Rebecca E Dombrowski,
Rebecca K Olin,
Richard Heath Coats,
Richard T Riggie,
Richard W Thornton,
Robert M Barbosa,
Robert Sausville,
Rose M Ashley,
Russell K Riley,
Samuel W Labinjo,
Santos E Camara,
Sarah B Tanksley,
Sarah M Meng,
Sarah M Napier,
Scott T Ballard,
Sean R Bryd,
Simone E Pitts,
Solomon Yimam (SY),
Stephen D Brown,
Susan M Jackson,
Susan P Bruederle,
Tina S Roecklein,
Tonia F Bernard,
Unnee Ranjan,
Wei Wang, PhD,
Yonggang Wang, PhD,
Zachary A Bogorad,
Zhongren Wu
Jennifer L Schmidt's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2009 | FDA 483 | CSL Behring L.L.C. - Form 483, 2009-06-05 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more